FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048779812> ?p ?o ?g. }

• W3048779812 abstract "Abstract Background Nucleos(t)ide analogues (NAs) are the first-line option against chronic hepatitis B (CHB). NAs produce potent suppression of viral replication with a small chance of HBsAg seroclearance and a high risk of virological relapse after discontinuation. The combined therapy of NAs plus traditional Chinese medicine (TCM) is widely accepted and has been recognized as a prospective alternative approach in China. Based on preliminary works, this study was designed to observe the therapeutic effect of TCM plus entecavir (ETV) against HBeAg-positive chronic hepatitis B with respect to reducing the recurrence risk after NA withdrawal. Methods/design The study is a nationwide, multicenter, double-blind, randomized, placebo-controlled trial with a duration of 120 weeks. A total of 18 hospitals and 490 eligible Chinese HBeAg-positive CHB patients will be enrolled and randomly allocated into the experimental group and control group in a 1:1 ratio. Patients in the experimental group will be prescribed TCM formulae (Tiaogan-BuXu-Jiedu granules) plus ETV 0.5 mg per day for consolidation therapy for 96 weeks. Patients in the control group will be prescribed TCM granule placebo plus ETV 0.5 mg per day for the same course. After consolidation therapy, all patients will discontinue their trial drugs and be closely monitored over the next 24 weeks. Once clinical recurrence (CR) occurs, ETV treatment will be restarted. The primary outcome is the cumulative rate of CR at the end of this trial. Conclusion This study is the first of its kind to observe therapeutic effects with respect to reducing recurrence after NA withdrawals after unified integrative consolidation therapy in the CHB population. Trial registration Chinese Clinical Trial Registry No. ChiCTR1900021232 . Registered on February 2, 2019" @default.
• W3048779812 created "2020-08-18" @default.
• W3048779812 creator A5002911533 @default.
• W3048779812 creator A5003681868 @default.
• W3048779812 creator A5004808990 @default.
• W3048779812 creator A5010989186 @default.
• W3048779812 creator A5012278873 @default.
• W3048779812 creator A5013179495 @default.
• W3048779812 creator A5013915624 @default.
• W3048779812 creator A5016525715 @default.
• W3048779812 creator A5018487471 @default.
• W3048779812 creator A5019903193 @default.
• W3048779812 creator A5020003474 @default.
• W3048779812 creator A5024856899 @default.
• W3048779812 creator A5027530439 @default.
• W3048779812 creator A5027562367 @default.
• W3048779812 creator A5035742116 @default.
• W3048779812 creator A5038760908 @default.
• W3048779812 creator A5038935592 @default.
• W3048779812 creator A5042681237 @default.
• W3048779812 creator A5047258558 @default.
• W3048779812 creator A5050298481 @default.
• W3048779812 creator A5061640859 @default.
• W3048779812 creator A5073746929 @default.
• W3048779812 creator A5074876914 @default.
• W3048779812 creator A5077410670 @default.
• W3048779812 creator A5083443028 @default.
• W3048779812 creator A5090374198 @default.
• W3048779812 date "2020-08-12" @default.
• W3048779812 modified "2023-09-29" @default.
• W3048779812 title "Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multi-center, double-blind, randomized controlled trial in China" @default.
• W3048779812 cites W1499646067 @default.
• W3048779812 cites W1507644714 @default.
• W3048779812 cites W1931610190 @default.
• W3048779812 cites W1990524419 @default.
• W3048779812 cites W2024339472 @default.
• W3048779812 cites W2038394904 @default.
• W3048779812 cites W2050571266 @default.
• W3048779812 cites W2062724733 @default.
• W3048779812 cites W2064731240 @default.
• W3048779812 cites W2076974448 @default.
• W3048779812 cites W2085434326 @default.
• W3048779812 cites W2125065061 @default.
• W3048779812 cites W2173698250 @default.
• W3048779812 cites W2174723704 @default.
• W3048779812 cites W2508430734 @default.
• W3048779812 cites W2528277687 @default.
• W3048779812 cites W2566914683 @default.
• W3048779812 cites W2581503467 @default.
• W3048779812 cites W2605785536 @default.
• W3048779812 cites W2737414455 @default.
• W3048779812 cites W2758682976 @default.
• W3048779812 cites W2767742777 @default.
• W3048779812 cites W2788119193 @default.
• W3048779812 cites W2791839818 @default.
• W3048779812 cites W2887259667 @default.
• W3048779812 cites W2890159366 @default.
• W3048779812 cites W2896802137 @default.
• W3048779812 cites W2903260180 @default.
• W3048779812 cites W2904463945 @default.
• W3048779812 cites W2904485024 @default.
• W3048779812 cites W2915810710 @default.
• W3048779812 cites W2999975000 @default.
• W3048779812 cites W3148993988 @default.
• W3048779812 doi "https://doi.org/10.1186/s13063-020-04417-9" @default.
• W3048779812 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7422608" @default.
• W3048779812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32787905" @default.
• W3048779812 hasPublicationYear "2020" @default.
• W3048779812 type Work @default.
• W3048779812 sameAs 3048779812 @default.
• W3048779812 citedByCount "2" @default.
• W3048779812 countsByYear W30487798122021 @default.
• W3048779812 countsByYear W30487798122023 @default.
• W3048779812 crossrefType "journal-article" @default.
• W3048779812 hasAuthorship W3048779812A5002911533 @default.
• W3048779812 hasAuthorship W3048779812A5003681868 @default.
• W3048779812 hasAuthorship W3048779812A5004808990 @default.
• W3048779812 hasAuthorship W3048779812A5010989186 @default.
• W3048779812 hasAuthorship W3048779812A5012278873 @default.
• W3048779812 hasAuthorship W3048779812A5013179495 @default.
• W3048779812 hasAuthorship W3048779812A5013915624 @default.
• W3048779812 hasAuthorship W3048779812A5016525715 @default.
• W3048779812 hasAuthorship W3048779812A5018487471 @default.
• W3048779812 hasAuthorship W3048779812A5019903193 @default.
• W3048779812 hasAuthorship W3048779812A5020003474 @default.
• W3048779812 hasAuthorship W3048779812A5024856899 @default.
• W3048779812 hasAuthorship W3048779812A5027530439 @default.
• W3048779812 hasAuthorship W3048779812A5027562367 @default.
• W3048779812 hasAuthorship W3048779812A5035742116 @default.
• W3048779812 hasAuthorship W3048779812A5038760908 @default.
• W3048779812 hasAuthorship W3048779812A5038935592 @default.
• W3048779812 hasAuthorship W3048779812A5042681237 @default.
• W3048779812 hasAuthorship W3048779812A5047258558 @default.
• W3048779812 hasAuthorship W3048779812A5050298481 @default.
• W3048779812 hasAuthorship W3048779812A5061640859 @default.
• W3048779812 hasAuthorship W3048779812A5073746929 @default.
• W3048779812 hasAuthorship W3048779812A5074876914 @default.
• W3048779812 hasAuthorship W3048779812A5077410670 @default.
• W3048779812 hasAuthorship W3048779812A5083443028 @default.
• W3048779812 hasAuthorship W3048779812A5090374198 @default.

• next